Related Experiment Video
Updated: Jul 16, 2025
Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
Can Nitric Oxide-Based Therapy Be Improved for the Treatment of Cancers? A Perspective
1Mechanistic Toxicology Branch, Division of Translational Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709, USA.
Abstract:
Since the early observations that nitric oxide (•NO) at high concentrations is cytotoxic to cancer cells and that it may play an important role in the treatment of human cancers, a significant number of compounds (NO-donors) have been prepared to deliver •NO to tumors. •NO also sensitizes various clinically active anticancer drugs and has been shown to induce the reversal of multi-drug resistance in tumor cells expressing ATP-binding cassette-transporter proteins. For the successful treatment of cancers, •NO needs to be delivered precisely to tumors, and its adverse toxicity must be limited. Like other chemotherapeutics, the precise delivery of drugs has been a problem and various attempts have been made, such as the encapsulation of drugs in lipid polymers, to overcome this. This prospective study examines the use of various strategies for delivering •NO (using NO-donors) for the treatment of cancers. Finding and utilizing such a delivery system is an important step in delivering cytotoxic concentrations of •NO to tumors without adverse reactions, leading to a successful clinical outcome for patient management.
Insights
Nitric oxide (NO) shows promise in cancer treatment by killing cancer cells and enhancing drug efficacy. This study explores novel NO-donor delivery systems to target tumors precisely and minimize side effects for better patient outcomes.
Area of Science:
- Oncology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Nitric oxide (NO) exhibits cytotoxicity against cancer cells at high concentrations.
- NO can sensitize anticancer drugs and reverse multi-drug resistance in cancer cells.
- Effective cancer treatment requires precise delivery of NO to tumors while limiting systemic toxicity.
Purpose of the Study:
- To examine various strategies for delivering nitric oxide (NO) using NO-donor compounds for cancer treatment.
- To identify effective NO delivery systems for precise tumor targeting and reduced adverse reactions.
Main Methods:
- Review of prospective studies on NO-donor compounds for cancer therapy.
- Analysis of drug delivery strategies, including lipid polymer encapsulation, for NO therapeutics.
- Evaluation of methods to achieve targeted delivery of cytotoxic concentrations of NO to tumors.
Main Results:
- Development of numerous NO-donor compounds for targeted NO delivery to tumors.
- Demonstration of NO's role in sensitizing anticancer drugs and overcoming multi-drug resistance.
- Exploration of advanced delivery systems to control NO release and localization.
Conclusions:
- Precise delivery of NO to tumors is crucial for effective cancer treatment.
- Advanced NO-donor delivery systems are essential to maximize therapeutic benefits and minimize toxicity.
- Successful implementation of these strategies can lead to improved clinical outcomes in cancer patient management.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
01:23Antihypertensive Drugs: Vasodilators